A tyrosine-rich domain within homeodomain transcription factor Nkx2-5 is an essential element in the early cardiac transcriptional regulatory machinery
Open Access
- 1 April 2006
- journal article
- Published by The Company of Biologists in Development
- Vol. 133 (7) , 1311-1322
Abstract
Homeodomain factor Nkx2-5 is a central component of the transcription factor network that guides cardiac development; in humans, mutations in NKX2.5 lead to congenital heart disease (CHD). We have genetically defined a novel conserved tyrosine-rich domain (YRD) within Nkx2-5 that has co-evolved with its homeodomain. Mutation of the YRD did not affect DNA binding and only slightly diminished transcriptional activity of Nkx2-5 in a context-specific manner in vitro. However, the YRD was absolutely essential for the function of Nkx2-5 in cardiogenesis during ES cell differentiation and in the developing embryo. Furthermore, heterozygous mutation of all nine tyrosines to alanine created an allele with a strong dominant-negative-like activity in vivo: ES cell↔embryo chimaeras bearing the heterozygous mutation died before term with cardiac malformations similar to the more severe anomalies seen in NKX2.5 mutant families. These studies suggest a functional interdependence between the NK2 class homeodomain and YRD in cardiac development and evolution, and establish a new model for analysis of Nkx2-5 function in CHD.Keywords
This publication has 56 references indexed in Scilit:
- T-box transcription factors and their roles in regulatory hierarchies in the developing heartDevelopment, 2005
- Foxh1 Is Essential for Development of the Anterior Heart FieldDevelopmental Cell, 2004
- Nkx2-5 Pathways and Congenital Heart DiseaseCell, 2004
- Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardiumJournal of Molecular and Cellular Cardiology, 2003
- Peduncle of Hydra and the heart of higher organisms share a common ancestral originGenesis, 2003
- Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoAGenes & Development, 2001
- Paracrine promotion of cardiomyogenesis in embryoid bodies by LIF modulated endodermDifferentiation, 2001
- The Homeodomain Transcription Factor NK-4 Acts as either a Transcriptional Activator or Repressor and Interacts with the p300 Coactivator and the Groucho CorepressorJournal of Biological Chemistry, 1999
- Elongation of Helix III of the NK-2 Homeodomain upon Binding to DNA: A Secondary Structure Study by NMRBiochemistry, 1994
- GAL4 fusion vectors for expression in yeast or mammalian cellsGene, 1992